Repository for Sepsis and Postresuscitation Samples
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01670383|
Recruitment Status : Recruiting
First Posted : August 22, 2012
Last Update Posted : May 1, 2018
|Condition or disease|
|Cardiac Arrest Sepsis|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Repository for Samples Collected From Sepsis and Postresuscitation Patients in Emergency Intensive Care Unit|
|Study Start Date :||July 2006|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||January 2021|
Adults (age over 16 years old) who have survived from nontraumatic cardiac arrest and admitted to ICU.
Adults (age over 16 years old) who satisfy the sepsis criteria (SIRS>=2 and infection is suspected for a cause) and admitted to the ICU.
- 1-month mortality [ Time Frame: 1 month ]All cause mortality within 1-month
- Hospital mortality [ Time Frame: until hospital discharge, an expected average of 2 weeks ]All cause mortality during hospitalization
- ICU length of stay [ Time Frame: Until ward transfer or discharge, an expected average of 7 days ]
- Favorable neurologic outcome [ Time Frame: at discharge, an expected average of 2 weeks and at 6-month ]
Favorable neurologic outcome is used for outcome measure in postresuscitation patients only.
Favorable neurologic outcome means cerebral performance category 1 and 2. This outcome is measured at discharge and 6-month after admission.
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01670383
|Contact: Kyung Su Kim, MD, PhDfirstname.lastname@example.org|
|Korea, Republic of|
|Seoul National University Hospital||Recruiting|
|Seoul, Korea, Republic of, 110-744|
|Contact: Kyung Su Kim, MD, PhD|
|Sub-Investigator: Kyung Su Kim, MD, PhD|
|Sub-Investigator: Woon Yong Kwon, MD, PhD|
|Principal Investigator: Gil Joon Suh, MD, PhD|
|Study Director:||Gil Joon Suh, Professor||Seoul National University Hospital|